Therefore, despite its lack of a cytoplasmic signaling domain, CD24 has the capacity to recruit crucial signaling molecules, such as EGFR, ERK, and AKT, and promote tumorigenicity in both cancer cells and CSCs. This evidence concerns the gene CD24 and cancer.